Current aspects of antirheumatic therapy in pregnancy planning, during pregnancy and breastfeeding
Active rheumatic disease is a known factor for increased fetomaternal risks during pregnancy. Remission or inactive disease should therefore be targeted to reduce these risks by using pregnancy-compatible antirheumatic drugs as recommended by international guidelines. Teratogenic antirheumatic drugs...
Gespeichert in:
Veröffentlicht in: | Zeitschrift für Rheumatologie 2021-10, Vol.80 (8), p.716 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | ger |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!